Oct 8, 2026 07:45AM
Oct 8, 2026 07:45AM
Jun 9, 2026 06:42PM
Jun 4, 2026 04:21PM
Jun 4, 2026 04:20PM
Jun 1, 2026 04:50PM
May 28, 2026 04:41PM Glass Lewis backs Pacira BioSciences director nominees
May 28, 2026 04:20PM
May 28, 2026 04:20PM
May 27, 2026 04:23PM
May 27, 2026 04:20PM
May 26, 2026 08:00AM
May 26, 2026 08:00AM
May 20, 2026 06:30AM Pacira BioSciences urges shareholders to vote for board nominees
May 20, 2026 06:30AM
May 13, 2026 08:00AM
May 12, 2026 04:01PM
May 12, 2026 04:01PM
May 5, 2026 04:20PM
May 5, 2026 04:20PM
Apr 28, 2026 04:20PM Pacira BioSciences Files Definitive Proxy Materials and Mails Letter to Shareholders
Oct 11, 2021 07:01AM
Oct 11, 2021 07:00AM
Oct 11, 2021 07:00AM
Oct 11, 2021 07:00AM
Oct 11, 2021 07:00AM
Feb 16, 2018 07:05AM
Sep 28, 2017 07:03AM UPDATE: Goldman Sachs Starts Pacira Pharmaceuticals (PCRX) at Neutral
Dec 1, 2016 10:10AM
Aug 3, 2016 02:51PM
May 20, 2015 04:30PM
Feb 26, 2015 11:01AM
Jan 29, 2015 03:13PM
Jun 3, 2014 10:19AM
Jun 2, 2014 08:07AM Goldman Sachs Starts Pacira Pharmaceuticals (PCRX) at Buy

193,285 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All